False data on Anti-HIV drug PrEP, found circulating in Facebook Ads

truveda drug

Medically incorrect targeted advertising has been found in various LGBTQ+ users’ newsfeeds, on the social media giant Facebook. The malignant ads claim that despite having a safer alternative in their inventory, the manufacturers kept selling the dangerous one called Truvada.

Crux of the Matter
  • Truvada, an anti-HIV drug PrEP, is a one-pill-a-day pharmaceutical that has been known to lower the possibility of HIV transmissions by 99%.
  • Reports suggest that the ads in speculation, are being paid for by the Virginia law firm, KBA Attorneys. It cites unspecified bone and kidney conditions as side-effects from Truvada and seeks to file a product-liability lawsuit against manufacturer Gilead Science.
  • Due to a drought of information about HIV-prevention in traditional media, Experts fear such misleading promotions in newsfeeds can prove to be a major setback for at-risk people reading them.
  • Consequently, an open letter has been published by LGBTQ+ advocacy organization, Glaad on 9th December, in an attempt to make Facebook commit to a review on the current advertising policies and debunk further claims done on public health statements.

HIV or the Human Immunodeficiency Viruses are two species of Lentivirus that causes HIV infection and over time acquired immunodeficiency syndrome, a condition in humans in which progressive failure of the immune system allows life-threatening opportunistic infections and cancers to thrive. This medical condition continues to disproportionately impact gay and bisexual men, transgender women, youth and communities of colour, with over 1.2 million people living with HIV in the United States More Info